Routine Primary Prophylaxis for Febrile Neutropenia with Biosimilar Granulocyte Colony-Stimulating Factor (Nivestim) or Pegfilgrastim Is Cost Effective in Non-Hodgkin Lymphoma Patients undergoing Curative-Intent R-CHOP Chemotherapy

OBJECTIVE: This study aims to compare the cost-effectiveness of various strategies of myeloid growth factor prophylaxis for reducing the risk of febrile neutropenia (FN) in patients with non-Hodgkin lymphoma in Singapore who are undergoing R-CHOP chemotherapy with curative intent. METHODS: A Markov...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiao Jun, Tang, Tiffany, Farid, Mohamad, Quek, Richard, Tao, Miriam, Lim, Soon Thye, Wee, Hwee Lin, Chan, Alexandre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752449/
https://www.ncbi.nlm.nih.gov/pubmed/26871584
http://dx.doi.org/10.1371/journal.pone.0148901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752449/
https://www.ncbi.nlm.nih.gov/pubmed/26871584
http://dx.doi.org/10.1371/journal.pone.0148901

Ejemplares similares